Purchase Order HHSN268201600067A
Award Date 2/24/16
Potential Completion Date 6/4/17
Potential Value $384K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
- This is a $303,238.66 firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina is the sole manufacturer of the specified sequencing platforms. This award is part of a larger Indefinite...
- This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...
- This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $81,254.25 and a period of performance ending on August 18, 2017. It does not have a set-aside designation. The contract provides for Illumina to deliver a range of genomic sequencing systems, reagents, consumables, and support services to the NHLBI. This includes Illumina's...
- This is a firm fixed-price delivery order issued by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. for Illumina sequencing kits and reagents. The $40,775.91 order is to support next-generation sequencing on Illumina instruments for NHLBI researchers and investigators. Illumina is the sole manufacturer of these proprietary sequencing systems. This delivery order is part of a larger Indefinite Delivery Contract the...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
- This firm fixed-price delivery order contract, valued at $5,088, was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract provides for the purchase of Illumina sequencing systems, reagents, and related products to support genomic research and analysis. Illumina has been a long-standing supplier of sequencing goods and services to various federal agencies, including the NIH, CDC, USDA, and VA. The...
- This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...
- This is a firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of laboratory equipment and supplies, specifically Illumina's genetic sequencing systems and related consumables. The contract has a total ceiling value of $84,812.59 and a period of performance through September 2, 2020. There is no set-aside designation for this award. Illumina has...
- This is a $115,587.90 firm fixed-price delivery order awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) to Illumina, Inc. to provide Illumina sequencing kits and reagents. The purpose is to support next-generation sequencing on Illumina instruments for NHLBI investigators. No set-aside designation was used. Illumina is a manufacturer of sequencing and genomic analysis solutions that has previously provided sequencing systems, reagents, and...